Overview of Fda-approved Gene Therapies in Pediatrics

Saturday, April 26, 2025

10:15am – 10:25am HST

Location: Convention Center: 318 B

Speaker(s)

Katherine Luzuriaga, MD (she/her/hers)
Professor, Vice Provost Research
UMass Chan Medical School, United States

Disclosure(s):

Katherine Luzuriaga, MD: Moderna (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator); Pfizer (Terminated, November 15, 2023) (Products/Services: Research Support including clinical trials & the principal or named investigator); Sanofi (Terminated, July 12, 2024) (Products/Services: Consultant)